Brief Report - (2025) Volume 10, Issue 4
Received: 01-Jul-2025, Manuscript No. JPNM-26-185950;
Editor assigned: 03-Jul-2025, Pre QC No. P-185950;
Reviewed: 17-Jul-2025, QC No. Q-185950;
Revised: 22-Jul-2025, Manuscript No. R-185950;
Published:
29-Jul-2025
, DOI: 10.37421/2472-100X.2025.10.357
Citation: Rodriguez, Amelia. ”Pediatric Epilepsy: Diagnosis, Treatment, and Future Therapies.” J Pediatr Neurol Med 10 (2025):357.
Copyright: © 2025 Rodriguez A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Pediatric epilepsy, a significant neurological challenge affecting children, is characterized by recurrent, unprovoked seizures, arising from diverse etiologies including genetic factors, structural brain abnormalities, metabolic disorders, and infections [1].
Genetic epilepsies in children are increasingly recognized as a primary cause of the disorder, with advances in genetic testing like whole-exome sequencing identifying numerous genes linked to specific epilepsy syndromes [2].
The ketogenic diet and its variations remain a cornerstone non-pharmacological intervention for drug-resistant epilepsy in pediatric populations, inducing a metabolic state to reduce seizure frequency and severity [3].
Epilepsy surgery presents a viable therapeutic avenue for children experiencing focal epilepsy refractory to conventional medical treatments, necessitating thorough pre-surgical evaluation [4].
Vagus nerve stimulation (VNS) stands as an established neuromodulation therapy for drug-resistant epilepsy in children, employing a device to deliver electrical impulses to the vagus nerve to mitigate seizures [5].
The diagnostic precision of electroencephalography (EEG) in delineating epilepsy syndromes in children can be substantially augmented through long-term video-EEG monitoring, enabling precise correlation of clinical and electrographic findings [6].
Neuroimaging modalities, particularly Magnetic Resonance Imaging (MRI), are indispensable in identifying the underlying structural origins of epilepsy in pediatric patients, with advanced sequences detecting subtle abnormalities [7].
The ongoing development of novel antiepileptic drugs (AEDs) aims for targeted mechanisms of action and improved tolerability in children, emphasizing the importance of understanding drug pharmacokinetics and pharmacodynamics in this population [8].
Developmental and epileptic encephalopathies (DEEs) constitute a group of severe epilepsy syndromes often manifesting in infancy, with genetic mutations frequently identified as the root cause, guiding therapeutic strategies through precise molecular diagnosis [9].
The profound impact of pediatric epilepsy extends beyond seizure control, influencing cognitive development, behavior, and overall quality of life, underscoring the critical role of multidisciplinary care teams in addressing these multifaceted challenges [10].
Pediatric epilepsy, a complex neurological disorder in children, is defined by recurrent, unprovoked seizures, stemming from a wide array of causes such as genetic predispositions, structural brain anomalies, metabolic imbalances, and infectious agents [1].
The genetic underpinnings of epilepsy in children are becoming increasingly apparent, with advanced diagnostic tools like whole-exome sequencing enabling the identification of specific genes associated with distinct epilepsy syndromes, paving the way for personalized therapeutic approaches [2].
The implementation of the ketogenic diet and its modified forms continues to be a significant non-pharmacological strategy for managing pediatric epilepsy that is resistant to medication, by creating a metabolic state that can effectively lessen seizure occurrences and intensity [3].
Surgical intervention for epilepsy is a recognized and effective option for pediatric patients with focal epilepsy that has not responded to medical therapies, where comprehensive pre-surgical assessments are paramount to identify the seizure focus and optimize surgical outcomes [4].
Vagus nerve stimulation (VNS) offers a well-established neuromodulatory treatment for children with epilepsy that is refractory to drug treatments, involving the implantation of a device that stimulates the vagus nerve to reduce the frequency and severity of seizures [5].
Enhancing the diagnostic accuracy of electroencephalography (EEG) for identifying various epilepsy syndromes in children can be achieved through prolonged video-EEG monitoring, which allows for a detailed correlation between observable clinical events and corresponding electrographic signals, vital for precise diagnosis and treatment planning [6].
Neuroimaging techniques, with MRI being particularly crucial, play a pivotal role in uncovering the structural causes of epilepsy in children; sophisticated imaging sequences can detect minute anomalies that might otherwise be missed, thereby aiding in diagnosis and surgical strategy development [7].
The continuous evolution in the field of antiepileptic drugs (AEDs) focuses on developing treatments with more specific targets and better safety profiles for pediatric use, highlighting the necessity of a thorough understanding of how these drugs are processed and affect children [8].
Developmental and epileptic encephalopathies (DEEs) represent a category of severe epilepsy syndromes typically beginning in infancy, where genetic mutations are frequently the underlying cause, and accurate molecular diagnoses are increasingly guiding treatment decisions [9].
The broader implications of pediatric epilepsy, reaching beyond seizure control to encompass effects on cognitive abilities, behavioral patterns, and overall life quality, necessitate the involvement of multidisciplinary teams to comprehensively address the needs of affected children and their families [10].
Pediatric epilepsy is a neurological disorder characterized by recurrent seizures with diverse causes including genetic factors, structural abnormalities, metabolic issues, and infections. Diagnosis relies on medical history, neurological exams, EEG, and neuroimaging. Treatments encompass antiepileptic drugs, ketogenic diets, vagus nerve stimulation, and surgery. Genetic advances are leading to targeted therapies. Long-term video-EEG monitoring and advanced neuroimaging enhance diagnostic accuracy. The impact of epilepsy extends to quality of life, requiring multidisciplinary care.
None
None
Journal of Pediatric Neurology and Medicine received 68 citations as per Google Scholar report
